Isthmus Partners’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-15,342
| Closed | -$210K | – | 171 |
|
2023
Q2 | $210K | Sell |
15,342
-49,130
| -76% | -$674K | 0.03% | 164 |
|
2023
Q1 | $1.46M | Buy |
64,472
+6,660
| +12% | +$151K | 0.21% | 100 |
|
2022
Q4 | $1.36M | Buy |
57,812
+1,173
| +2% | +$27.6K | 0.2% | 100 |
|
2022
Q3 | $1.48M | Buy |
56,639
+3,925
| +7% | +$102K | 0.25% | 89 |
|
2022
Q2 | $1.16M | Buy |
52,714
+12,491
| +31% | +$274K | 0.22% | 98 |
|
2022
Q1 | $1.8M | Buy |
40,223
+2,414
| +6% | +$108K | 0.3% | 74 |
|
2021
Q4 | $1.62M | Buy |
37,809
+28,247
| +295% | +$1.21M | 0.27% | 87 |
|
2021
Q3 | $636K | Sell |
9,562
-15
| -0.2% | -$998 | 0.12% | 122 |
|
2021
Q2 | $702K | Buy |
+9,577
| New | +$702K | 0.12% | 119 |
|